Skip to content

Study on the ameliorating effect of probiotics on ovarian hyperstimulation syndrome after ovulation induction in infertile women

Study on the ameliorating effect of probiotics on ovarian hyperstimulation syndrome after ovulation induction in infertile women

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400090254
Enrollment
Unknown
Registered
2024-09-26
Start date
2024-10-02
Completion date
Unknown
Last updated
2026-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ovarian hyperstimulation syndrome

Interventions

Sponsors

Reproductive Hospital Affiliated to Jiangxi University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: Normal healthy women: 1. Healthy women with regular menstruation (menstrual cycle is 21-35 days, menstrual period is 2-7 days). 2. Age 20-40 years old. 3. Those who voluntarily take the test and sign the informed consent form. Patients with ovarian hyperstimulation syndrome: (1) history of ovulation induction or ovarian stimulation; (2) have received injections that trigger oocyte maturation; (3) Abdominal distension/gastric distention, diarrhea/nausea/vomiting, ovarian enlargement, meeting the OHSS mild diagnostic criteria; (4) occurs during ovulation induction or within 10 days after triggering; (5) Age between 20~40 years old; (6) The enrolled patients were all in line with the diagnosis of infertility; (7) Voluntarily sign the informed consent form.

Exclusion criteria

Exclusion criteria: Normal healthy women: 1. Menstrual disorders in the past two months. 2. Those who are pregnant, lactating and lactating. 3. Have taken antibiotics, probiotics, contraceptives and other drugs in the past month. 4. Abnormal liver and kidney function. 5. Body weight: 18kg/m2> BMI>25kg/m2, accompanied by other organic diseases. 6. Those who are participating in other clinical trials. Patients with ovarian hyperstimulation syndrome: (1) abnormal liver and kidney function, with a history of hepatitis B. (2) Patients who have used antibiotics, probiotics and contraceptives in the past month. (3) Body weight: 18kg/m2> BMI>25kg/m2, accompanied by other organic diseases. (4) Malignant tumors. (5) Patients with unexplained vaginal bleeding who are not suitable for ovulation induction treatment. (6) Accompanied by other endocrine diseases. (7) Moderate to severe OHSS after egg retrieval. (8) OHSS occurs after pregnancy. (9) Those who are participating in other clinical investigations.

Design outcomes

Primary

MeasureTime frame
Symptoms of self-awareness;Ovarian function;Stool high-throughput sequencing;

Secondary

MeasureTime frame
Ovulation induction outcome;Blood hormone levels;Biochemical indicators;

Countries

China

Contacts

Public ContactChen Weijun

Reproductive Hospital Affiliated to Jiangxi University of Traditional Chinese Medicine

112307068@qq.com+86 138 0706 2856

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 20, 2026